DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02496 YZYBIO-B

Closed Add to Porfolio
Index Constituent : None
Major Shareholders Yuan Qian & Associates (28.68%)
CSPC NBP Pharmaceutical Co., Ltd. (26.43%)
Wen Zhicheng (8.71%)
Guo Hongwei & Associates (6.99%)		 Sector Health Care & Biotechnology
Web Site http://www.yzybio.com Tel (86 27) 8266-8988
Email info@yzybio.com Fax N/A
Related Equities N/A
Principal Activities The principal activities are mainly committed to develop bispecific antibody (BsAb)-based therapies to treat cancer-associated complications, cancer and age-related ophthalmologic diseases.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top